Correspondence 0001104659-24-074820 from STANDARD BIOTOOLS INC. (LAB) (CIK 0001162194) (LAB)
STANDARD BIOTOOLS INC. (LAB) (CIK 0001162194)
Date: June 25, 2024 · CIK: 0001162194 · Accession: 0001104659-24-074820
AI Filing Summary & Sentiment
File numbers found in text: 333-280321
Letter
Standard BioTools Inc.
2 Tower Place, Suite 2000
South San Francisco, CA
June 25, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Attention: Nicholas O'Leary
RE: Standard BioTools Inc.
Registration Statement on Form S-3
File No. 333-280321
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, Standard BioTools Inc. (the “Company”) hereby requests acceleration of the effective date of the Registration Statement on Form S-3 (File No. 333-280321) (the “Registration Statement”) so that it may become effective at 4:00 p.m. Eastern Time on Thursday, June 27, 2024, or as soon as possible thereafter.
The Company hereby authorizes John T. Rudy, Esq. of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. to orally modify or withdraw this request for acceleration.
The Company respectfully requests that it be notified of such effectiveness by a telephone call to Mr. Rudy at (617) 348-3050 and that such effectiveness also be confirmed in writing. Any questions regarding this request may be addressed to Mr. Rudy.
Very truly yours,
Standard biotools INC.
Show Raw Text
CORRESP
1
filename1.htm
Standard BioTools Inc.
2 Tower Place, Suite 2000
South San Francisco, CA
June 25, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Attention: Nicholas O'Leary
RE: Standard
BioTools Inc.
Registration
Statement on Form S-3
File
No. 333-280321
Request
for Acceleration of Effectiveness
Ladies and Gentlemen:
In accordance with Rule 461
promulgated under the Securities Act of 1933, as amended, Standard BioTools Inc. (the “Company”) hereby requests
acceleration of the effective date of the Registration Statement on Form S-3 (File No. 333-280321) (the “Registration
Statement”) so that it may become effective at 4:00 p.m. Eastern Time on Thursday, June 27, 2024, or as soon as
possible thereafter.
The Company hereby authorizes
John T. Rudy, Esq. of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. to orally modify or withdraw this request for acceleration.
The Company respectfully
requests that it be notified of such effectiveness by a telephone call to Mr. Rudy at (617) 348-3050 and that such effectiveness
also be confirmed in writing. Any questions regarding this request may be addressed to Mr. Rudy.
Very truly yours,
Standard biotools INC.
/s/ Michael Egholm, Ph.D.
Michael Egholm, Ph.D.
President and Chief Executive Officer
cc: Standard BioTools Inc.
Jeffrey Black, Chief Financial Officer
Agnieszka Gallagher, Esq., Senior Vice President and
Chief Legal Officer
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
John T. Rudy, Esq.